Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study

Transplantation Proceedings

Volumn 42, Issue 4, 2010, Pages 1114-1117

  Favi, E ^a   Gargiulo, A ^a   Spagnoletti, G ^a   Salerno, M P ^a   Silvestrini, N ^a   Valente, I ^a   Citterio, F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGE; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT INFECTION; GRAFT SURVIVAL; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CREATININE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT FUSION PROTEINS; RENAL DIALYSIS; TISSUE DONORS;

EID: 77952557551     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.073     Document Type: Article

References (10)

1. Roodnat J.I., Zietse R., Mulder P.G., et al. The vanishing importance of age in renal transplantation. Transplantation 67 (1999) 576
2. Fritsche L., Horstrup J., Budde K., et al. Old for old kidney allocation allows successful expansion of the donor and recipients pool. Am J Transplant 3 (2003) 1434
3. Bodingbauer M., Pakrah B., Steininger R., et al. The advantage of allocating kidneys from old cadaveric donors to old recipients: a single center experience. Clin Transplant 20 (2006) 471
4. Singh N., Nori U., and Pesavento T. Kidney transplantation in the elderly. Curr Opin Organ Transplant 14 (2009) 380
5. Basar H., Soran A., Shapiro R., et al. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation 67 (1999) 1191
6. Doyle S.E., Matas A.J., Gillingham K., and Rosemberg M.E. Predicting clinical outcome in the elderly renal transplant recipient. Kidney Int 57 (2000) 2144
7. Meier-Kriesche H.U., Ojo A., Hanson J., et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 69 (2000) 885
8. Kuypers D.R. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging 26 (2009) 715
9. Ekberg H., Tedesco-Silva H., Demirbas A., et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357 (2007) 2562
10. De Fijter J.W., Mallat M.J., Doxiadis I.I., et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 12 (2001) 1538